Latest News & Features
Big Pharma
Kerri-Ann Limbeek, trial lead for Ravgen, tells Sarah Speight that a compelling narrative was key to winning the case against their larger rival. 25 January 2024
Biotechnology
Despite the clamour for guidance, applicants, attorneys, and lawyers may be in for a frustrating wait before the UK updates AI protections, says Rebecca Lawrence of DLA Piper. 25 January 2024
Asia
Five cases in which preliminary injunctions were granted are examined by Takanori Abe of Abe & Partners. 23 January 2024
Big Pharma
Life science attorneys should see some notable developments relating to artificial intelligence, patent eligibility and the Fintiv rule, write Manita Rawat and Alexander Stein of Morgan Lewis. 2 January 2024
Biotechnology
Mark Hatch-Miller, who led the trial team at Susman for Globus, tells Sarah Speight how this spinal implant patent dispute, brought by a Johns Hopkins neurosurgeon, was a “heavy lift”. 21 December 2023
Asia
A Korean district court has applied a landmark ruling in a complicated vaccine dispute involving Pfizer, explain Young Kim, Yu-Seog WON, In Hwan Kim, and Amy Oh of Kim & Chang. 12 December 2023
Biotechnology
Patent applications need to offer the full picture when it comes to scientific research, finds Marisa Woutersen at LSPN Europe. 30 November 2023
Europe
Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger. 28 November 2023
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares. 28 November 2023
Biotechnology
Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF. 21 November 2023